Baselight
Sign In

Stocks

April 30, 2026

Anomaly01STOCKS

Celestica falls 14% on earnings beat and raise amid execution concerns

Celestica (CLS.TO) shed roughly C$10 billion in market value on April 29 despite reporting Q1 2026 results with 53% year-on-year revenue growth and raised full-year 2026 revenue guidance to $19.0 billion from $17.0 billion, while guiding to adjusted EPS of $10.15. The updated outlook implies roughly a 28% half-over-half revenue ramp in the second half of 2026, raising investor concerns about execution risk. The stock climbed about 50% in the past month and is up roughly 380% over the past year, which left little room for anything short of spectacular results.

Celestica falls 14% on earnings beat and raise amid execution concerns
Inflection Point02STOCKS

Cenovus (CVE.TO) breaks above 52-week high with 3.3% gain on strong analyst support

Cenovus Energy (CVE.TO) closed at C$39.37 on April 29, clearing its prior 52-week high of C$38.50 and extending a 16% rally from C$33.55 on April 17. The move coincides with strong earnings expectations: the FY EPS consensus of C$3.87 implies 88% growth versus the year-ago actual of C$2.06, and analysts maintain a Strong Buy consensus rating.

Cenovus (CVE.TO) breaks above 52-week high with 3.3% gain on strong analyst support
Trend Shift03STOCKS

CIBC (CM.TO) records 12 FY EPS upgrades with zero cuts; consensus up 7% in 30 days

Canadian Imperial Bank of Commerce (CM.TO) recorded 12 upward FY EPS revisions in 7 days with zero cuts. The FY consensus rose from C$9.56 thirty days ago to C$10.21 today (+6.8%), yet the stock fell 1.5% on April 29 to C$147.56, just 2.4% below its 52-week high of C$151.23, as Canadian bank stocks pulled back broadly.

CIBC (CM.TO) records 12 FY EPS upgrades with zero cuts; consensus up 7% in 30 days
Trend Shift04STOCKS

Docebo (DCBO.TO) gets 7 EPS upgrades with zero cuts across all four periods; Zacks Strong Buy

Docebo (DCBO.TO) received 7 upward EPS revisions in 7 days across every reporting period — current quarter, next quarter, current year, and next year — with zero cuts, a clean sweep rare in the dataset. Zacks upgraded the stock to Strong Buy on April 27 citing 59% implied upside. The stock is up 24% from its April low of C$20.36 to C$25.30, though still 46% below its 52-week high of C$46.96.

Docebo (DCBO.TO) gets 7 EPS upgrades with zero cuts across all four periods; Zacks Strong Buy
Inflection Point05STOCKS

CPKC (CP.TO) Q1 profit falls 6.4%, misses estimates; 21 EPS cuts in 30 days

Canadian Pacific Kansas City (CP.TO) reported Q1 2026 results on April 29 showing a 6.4% year-on-year profit decline and misses on both earnings (−2.56%) and revenue (−0.57%), sending the stock down 2.45% to C$115.30. The FY EPS consensus has been cut 4 times in 7 days and 21 times in 30 days, with the current-quarter estimate down 4.4% from thirty days ago to C$1.07.

CPKC (CP.TO) Q1 profit falls 6.4%, misses estimates; 21 EPS cuts in 30 days
Trend Shift06STOCKS

Colgate India (COLPAL.NS) absorbs 19 FY EPS cuts in 7 days — second-worst in dataset

Colgate-Palmolive India (COLPAL.NS) recorded 19 downward FY EPS revisions in 7 days with just 3 upgrades, the second-largest negative revision count in today's dataset after Cipla. The next-quarter consensus fell 2.5% from ₹12.78 to ₹12.46 in the same window, and the stock closed at ₹2,132 on April 28 — 22% below its 52-week high of ₹2,747.

Colgate India (COLPAL.NS) absorbs 19 FY EPS cuts in 7 days — second-worst in dataset

Share link

Anyone who has the link will be able to view this.